Entry specification
- SKU
- PAL-CJC1295-RUO
- Format
- Lyophilised research material
- Research size
- 2 mg
- Status
- Restricted inquiry
- Purity
- Research grade, batch documented
- Classification
- Synthetic GHRH analogue (with or without DAC)
Documentation
Documents associated with this entry
Batch record
Analytical summary
Storage note
Linked profile
CJC-1295 research context
CJC-1295 is a synthetic GHRH analogue investigated in early-phase human pharmacology studies and in GHRH-knockout rodent models. Published primary human research is limited to small Phase I/II pharmacokinetic and pharmacodynamic trials.
Endocrine pharmacokinetic research
GHRH-receptor binding studies
Peptide stability and analogue comparison
Knockout-model rescue investigations
Related reading
How Peptides Are Studied
An introduction to common laboratory approaches used to evaluate peptide behaviour.
6 min
Read articleReceptor Signalling Context for Peptide Fragments
A research-context overview of peptide fragments studied for receptor-level signalling behaviour.
7 min
Read article